Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Aronow

Showing results (461-470 of 1,356) with videos related to

Pageof 136
Sort By:
The American Journal of Cardiology|July 22, 1998
Risk factors for new thromboembolic stroke in patients > or = 62 years of age with chronic atrial fibrillationW S Aronow, C Ahn, I Kronzon, et al.
California Medicine|September 1, 1971
Myocardial infarction and carbohydrate metabolism relating to diabetes mellitusW S Aronow, B V Suryanarayana, J R Kent
Cardiology in Review|August 28, 2024
Ninerafaxstat in the Treatment of Diabetic Cardiomyopathy and Nonobstructive Hypertrophic CardiomyopathyJared M Feldman, William H Frishman, Wilbert S Aronow
Cardiology in Review|January 3, 2024
Sacubitril-Valsartan (LCZ696) in the Treatment of Systemic Hypertension: An Updated Review of Neprilysin Inhibition Combined with Angiotensin II Receptor BlockadeMiriam E Katz, William H Frishman, Wilbert S Aronow
Cardiology in Review|February 15, 2024
Emerging Therapies for Treatment-Resistant Hypertension: A Review of Lorundrostat and Related Selective Aldosterone Synthase InhibitorsJared M Feldman, William H Frishman, Wilbert S Aronow
Cardiology in Review|June 16, 2026
Ischemia-Modified Albumin: Review of a Novel Cardiac Biomarker and Its Clinical Applications in Cardiovascular DiseaseMuhammad Saad Furqan, William H Frishman, Wilbert S Aronow
Expert Opinion on Drug Safety|March 20, 2020
The relationship between atypical antipsychotics drugs, QT interval prolongation, and torsades de pointes: implications for clinical useJuan Carlos Ruiz Diaz, Daniel Frenkel, Wilbert S Aronow
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|June 4, 2005
Use of hormone replacement therapy by postmenopausal women after publication of the Women's Health Initiative TrialJose Ness, Wilbert S Aronow, Erin Newkirk, et al.
Cardiology|October 29, 2005
Electrocardiographic abnormalities in patients with right ventricular dilation due to acute pulmonary embolismRishi Sukhija, Wilbert S Aronow, Chul Ahn, et al.
Catheterization and Cardiovascular Diagnosis|January 1, 1976
Treadmill exercise testing of mass screening for coronary risk factorsW H Allen, W S Aronow, D De Cristofaro
Pageof 136

Showing results (461-470 of 1,356) with videos related to

Sort By:
Pageof 136
The American Journal of Cardiology|July 22, 1998
Risk factors for new thromboembolic stroke in patients > or = 62 years of age with chronic atrial fibrillationW S Aronow, C Ahn, I Kronzon, et al.
California Medicine|September 1, 1971
Myocardial infarction and carbohydrate metabolism relating to diabetes mellitusW S Aronow, B V Suryanarayana, J R Kent
Cardiology in Review|August 28, 2024
Ninerafaxstat in the Treatment of Diabetic Cardiomyopathy and Nonobstructive Hypertrophic CardiomyopathyJared M Feldman, William H Frishman, Wilbert S Aronow
Cardiology in Review|January 3, 2024
Sacubitril-Valsartan (LCZ696) in the Treatment of Systemic Hypertension: An Updated Review of Neprilysin Inhibition Combined with Angiotensin II Receptor BlockadeMiriam E Katz, William H Frishman, Wilbert S Aronow
Cardiology in Review|February 15, 2024
Emerging Therapies for Treatment-Resistant Hypertension: A Review of Lorundrostat and Related Selective Aldosterone Synthase InhibitorsJared M Feldman, William H Frishman, Wilbert S Aronow
Cardiology in Review|June 16, 2026
Ischemia-Modified Albumin: Review of a Novel Cardiac Biomarker and Its Clinical Applications in Cardiovascular DiseaseMuhammad Saad Furqan, William H Frishman, Wilbert S Aronow
Expert Opinion on Drug Safety|March 20, 2020
The relationship between atypical antipsychotics drugs, QT interval prolongation, and torsades de pointes: implications for clinical useJuan Carlos Ruiz Diaz, Daniel Frenkel, Wilbert S Aronow
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|June 4, 2005
Use of hormone replacement therapy by postmenopausal women after publication of the Women's Health Initiative TrialJose Ness, Wilbert S Aronow, Erin Newkirk, et al.
Cardiology|October 29, 2005
Electrocardiographic abnormalities in patients with right ventricular dilation due to acute pulmonary embolismRishi Sukhija, Wilbert S Aronow, Chul Ahn, et al.
Catheterization and Cardiovascular Diagnosis|January 1, 1976
Treadmill exercise testing of mass screening for coronary risk factorsW H Allen, W S Aronow, D De Cristofaro
Pageof 136